Skip to main content Skip to section navigation Skip to footer

Aerami Therapeutics Holdings, Inc.

  • Home
  • About
  • Inhalation Technology
  • Pipeline
  • News & Media
    • Press Releases
    • In The News
    • Email Alerts
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • In The News
  • Email Alerts
Jul 23, 2020 8:00am EDT

Aerami Therapeutics to Present at the LifeSci Partners Summer Symposium

Jun 08, 2020 8:15am EDT

Aerami Therapeutics Signs a Global License Agreement with Vectura Group, Adding an Inhaled Therapy for Patients with Pulmonary Arterial Hypertension to Their Pipeline

Feb 05, 2020 8:30am EST

Aerami Therapeutics Appoints Timm Crowder as Chief Operating Officer

Nov 11, 2019 8:00am EST

Aerami Therapeutics to Present Clinical Data on Dance 501 Inhaled Human Insulin at the 19th Diabetes Technology Meeting

Sep 25, 2019 7:30am EDT

Dance Biopharm Announces Rebranding to Aerami Therapeutics Reflecting a Broadened Strategic Focus on Inhaled Therapies for Chronic Diseases

  • arrow_back
  • 1
  • 2
rss_feed News RSS
  • Visit us on Twitter
  • Visit us on Linkedin
©2023 Aerami Therapeutics Holdings, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap

We use cookies to offer you a better browsing experience, including personalized advertising. By continuing to use the site you agree to their use.

Privacy Policy